Elicio Therapeutics, Inc.

Nasdaq:ELTX

Pharmaceutical Preparations·BOSTON, MA

Elicio is a male Spanish given name.

CEO

Connelly Robert

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

51 shown

Filed	Type	Description
9/17/25	Reg FD	Regulation FD Disclosure	→
8/12/25	Other	Other Events	→
8/5/25	Other	Other Events	→
6/4/25	Agreement	Entry into a Material Definitive Agreement	→
5/20/25	Vote	Submission of Matters to a Vote of Security Holders	→
3/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

35 shown

Filed	Form	Description
3/2/26	S-3/A	S-3/A	→
2/27/26	S-3	S-3	→
11/13/25	S-3	S-3	→
4/9/25	ARS	ARS	→
3/31/25	S-8	S-8	→
1/30/25	424B5	424B5	→
↓

Filing History(347 filings)

TypeDateAccessionPeriodSize

S-3/A

Mar 2, 2026

0001628280-26-013187S-3/A

—

94.7 KB

S-3

Feb 27, 2026

0001628280-26-012826S-3

—

1.2 MB

Feb 3, 2026

0001601485-26-000010FORM 4

Feb 2, 2026

7.4 KB

Feb 3, 2026

0001601485-26-000008FORM 4

Feb 2, 2026

7.4 KB

Feb 3, 2026

0001601485-26-000006FORM 4

Feb 2, 2026

7.4 KB

Feb 3, 2026

0001601485-26-000002FORM 4

Feb 2, 2026

7.4 KB

Dec 10, 2025

0001601485-25-000130FORM 4

Dec 9, 2025

6.7 KB

EFFECT

Dec 3, 2025

9999999995-25-003510

—

1.8 KB

S-3

Nov 13, 2025

0001628280-25-052119S-3

—

402.6 KB

10-Q

Nov 13, 2025

0001601485-25-00012410-Q

Sep 30, 2025

7.4 MB

8-K

Nov 13, 2025

0001601485-25-0001238-K

Nov 13, 2025

2.0 MB

SCHEDULE 13G/A

Oct 7, 2025

0002050492-25-000003

—

7.1 KB

8-K

Sep 17, 2025

0001193125-25-2055228-K

Sep 17, 2025

1.8 MB

8-K

Aug 12, 2025

0001601485-25-0001148-K

Aug 12, 2025

1.9 MB

10-Q

Aug 7, 2025

0001601485-25-00011110-Q

Jun 30, 2025

7.2 MB

8-K

Aug 7, 2025

0001601485-25-0001088-K

Aug 7, 2025

1.9 MB

8-K

Aug 5, 2025

0001601485-25-0000998-K

Aug 5, 2025

1.6 MB

Jun 4, 2025

0000950170-25-0817414

Jun 3, 2025

6.9 KB

SCHEDULE 13D/A

Jun 4, 2025

0000950170-25-081739

—

11.8 KB

8-K

Jun 4, 2025

0001601485-25-0000968-K

Jun 4, 2025

23.6 MB

May 20, 2025

0001601485-25-000090FORM 4

May 19, 2025

5.5 KB

May 20, 2025

0001601485-25-000089FORM 4

May 19, 2025

5.5 KB

May 20, 2025

0001601485-25-000088FORM 4

May 19, 2025

5.5 KB

May 20, 2025

0001601485-25-000087FORM 4

May 19, 2025

5.4 KB

May 20, 2025

0001601485-25-000086FORM 4

May 19, 2025

5.5 KB

25 filings shown

Filed	Form	Description
4/9/25	DEF 14A	DEF 14A	→
9/27/24	DEF 14A	DEF 14A	→
9/17/24	PRE 14A	PRE 14A	→
4/27/22	DEFA14A	DEFA14A	→
4/27/22	DEF 14A	DEF 14A	→

Elicio Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(347 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
12/10/25	4	4	→
6/4/25	4	4	→
↓

Filed	Form	Description
12/3/25	EFFECT	EFFECT	→
10/7/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/4/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
5/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/7/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/5/25	SCHEDULE 13G	SCHEDULE 13G	→
↓